PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology

Advanced search


Full Text:


Private health spending in modern developed countries varies considerably depending on the national policy objectives, selected regulatory instruments as well as general socio-economic conditions.

The objective of this paper is to analyze key determinants of private health spending.

Materials and Methods. To achieve this objective we analyze academic works dealing with theoretical and empirical studies of private health spending.

Results. From the analysis the effects of private health spending determining national health financing policy, significant discretionary (breadth and depth of social healthcare system, public health expenditure, regulatory measures on cost sharing, paid medical services, voluntary health insurance) and non-discretionary factors (relative health services price, income and its distribution, age structure, level of education, political preferences) were highlighted.

Conclusion. In developed countries priorities of health private spending regulatory policy now are ensuring accessibility of essential health care and preventing consumer’s moral hazard. The most significant discretionary factor influencing the share and amount of private health spending is the management of state guarantees of free medical care; the most significant non-discretionary factor is the income and its distribution.

About the Authors

O. A. Zarubina
Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution
Russian Federation

junior research fellow of Financial and strategic management centre, Financial research institute. Address: Nastasyinsky per., 3-2, Moscow, 127006, Russia. Tel.: +7(495)6997414

N. N. Sisigina
Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution Russian Presidential Academy of National Economy and Public Administration
Russian Federation

research fellow of Institute for social analysis and forecasting, Russian academy of national economy and public administration, junior researcher of Tax policy center, Financial research institute, Address: Nastasyinsky per., 3-2, Moscow, Russia, 127006. Tel.: +7(495)6997414.


1. Report on world health. Health systems financing: the path to universal coverage of health care of the population. World Health Organization [Doklad o sostoyanii zdravookhraneniya v mire. Finansirovanie sistem zdravookhraneniya: put’ k vseobshchemu okhvatu naseleniya mediko-sanitarnoi pomoshch’yu. Vsemirnaya organizatsiya zdravookhraneniya (in Russian)]. Geneva. 2010.

2. Maksimova L. V., Omel’yanovskii V. V., Sura M. V. Meditsinskie tekhnologii. Otsenka i vybor. 2014; 1 (15): 37-45.

3. Arrow K. J. Uncertainty and the welfare economics of medical care. American economic review. 1963; 53 (5): 941-973.

4. Bilger M. and Chaze J.-P. What drives individual health expenditure in Switzerland? Swiss Journal of Economics and Statistics. 2008; 144 (III): 337-358.

5. Busse R., Blumel M. Germany: health system review. Health Systems in Transition. 2014; 16 (2): 1-296.

6. Cavalieri M., Guccio C. Health expenditure in Italy: a regional analysis of the public- private mix. Societa italiana di economia pubblica. 2006; 1-32.

7. Chevreul K. et al. France: Health system review. Health Systems in Transition. 2010; 12 (6): 1-291.

8. De Pietro C. et al. Switzerland: Health system review. Health Systems in Transition. 2015; 17 (4): 1-288.

9. Di Matteo L. Policy choice or economic fundamentals: what drives the public–private health expenditure balance in Canada? Health Economics, Policy and Law. 2009; 4 (1): 29-53.

10. Di Matteo L. The determinants of the public–private mix in Canadian health care expenditures: 1975–1996. Health Policy. 2000; 2: 87-112.

11. Emmerson C., Frayne C., Goodman A. Should private medical insurance be subsidized? Health care United Kingdom. 2001; 51 (4): 49-65.

12. Farnsworth D. Moral Hazard in Health Insurance: Are Consumer-Directed Plans the Answer? Annals of Health Law. 2006; 15 (2): 251-273.

13. Gregory P. Marchildon. Canada: Health system review. Health Systems in Transition. 2013; 5 (1): 1-179.

14. Gruber J. The impact of the tax system on health insurance coverage. International journal of health care finance and economics. 2001; 1: 293-304.

15. Gruber J. The Role of Consumer Copayments for Health Care: Lessons from the RAND Health Experiment and Beyond. Kaiser Family Foundation, 2007. Accessed: 12.10.2016.

16. Himmelstein D. U. et al. Medical bankruptcy in the United States, 2007: results of a national study. The American Journal of Medicine. 2009; 122: 741-746.

17. Hitiris T. Prescription charges in the United Kingdom: a critical review. Discussion Papers in Economics No 2000/04. University of York Press.

18. Houweling T. A.J. et al. Huge poor-rich inequalities in maternity care: an international comparative study of maternity and child care in developing countries. Bulletin of the World Health Organization. 2007; 85: 745-754.

19. Moene K. O., Wallerstein M. Inequality, social insurance, and redistribution. American Political Science Review. 2001; 859-874.

20. Mossialos E., Le Grand J. (eds). Health care and cost containment in the European Union. Aldershot, Ashgate, 1999.

21. Mou H. The political economy of the public-private mix in heath expenditure: An empirical review of thirteen OECD countries. Health policy. 2013; 113 (3): 270-283.

22. O’Connell J. M. The relationship between health expenditures and the age structure of the population in OECD countries. Health economics. 1996; 5 (6): 573-578.

23. OECD Health Statistics 2016. Accessed: 10.10.2016.

24. Sanwald A., Theurl E. What drives out of pocket health expenditures of private households? Empirical evidence from the Austrian household budget survey. University of Innsbruck. Working Papers in Economics and Statistics. 2014; 4. Accessed: 12.10.2016.

25. Thomson S., Mossialos E. What are the equity, efficiency, cost containment and choice implications of private health-care funding in western Europe? Copenhagen, WHO Regional Office for Europe (Health Evidence Network report), 2004. Accessed: 12.10.2016.

26. Xu K. et al. Exploring the thresholds of health expenditure for protection against financial risk. World health report 2010 background paper, no. 19. Accessed: 12.10.2016.

27. Xu K. et al. Protecting households from catastrophic health spending. Health Affairs. 2007; 26 (4): 972-983.

28. Xu K., Saksena P., Durairaj V. The drivers of catastrophic expenditure: outpatient services, hospitalization or medicines? World health report 2010 background paper, no.

29. Accessed: 12.10.2016.

For citation:

Zarubina O.A., Sisigina N.N. FACTORS AND EFFECTS OF PRIVATE HEALTH SPENDING. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2016;9(4):24-30. (In Russ.)

Views: 161

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)